Vivos Therapeutics (NASDAQ:VVOS) just reported results for the fourth quarter of 2023.
- Vivos Therapeutics reported earnings per share of -$3.05. This was below the analyst estimate for EPS of -$1.90.
- The company reported revenue of $3.25 million.
- This was 4.75% worse than the analyst estimate for revenue of $3.41 million.